Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
CCAAT-Enhancer-Binding Protein-alpha | 54 | 2019 | 129 | 7.580 |
Why?
|
Trans-Activators | 50 | 2021 | 2922 | 4.530 |
Why?
|
Hematopoietic Stem Cells | 71 | 2021 | 3364 | 4.260 |
Why?
|
Granulocytes | 46 | 2020 | 545 | 4.150 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 31 | 2021 | 284 | 3.480 |
Why?
|
Proto-Oncogene Proteins | 63 | 2021 | 4555 | 3.450 |
Why?
|
Leukemia, Myeloid, Acute | 48 | 2021 | 3485 | 3.340 |
Why?
|
Hematopoiesis | 50 | 2021 | 2049 | 2.710 |
Why?
|
Promoter Regions, Genetic | 75 | 2021 | 5863 | 2.620 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 30 | 2021 | 344 | 2.470 |
Why?
|
Gene Expression Regulation, Leukemic | 28 | 2021 | 649 | 2.430 |
Why?
|
Cell Differentiation | 98 | 2021 | 11460 | 2.340 |
Why?
|
Transcription Factors | 68 | 2021 | 12120 | 2.310 |
Why?
|
Leukemia, Myeloid | 23 | 2020 | 705 | 2.300 |
Why?
|
Antigens, CD34 | 23 | 2012 | 656 | 1.640 |
Why?
|
Gene Expression Regulation | 56 | 2021 | 12049 | 1.580 |
Why?
|
Myeloid Cells | 19 | 2021 | 799 | 1.550 |
Why?
|
Oncogene Proteins, Fusion | 22 | 2021 | 1574 | 1.520 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 12 | 2021 | 683 | 1.380 |
Why?
|
DNA-Binding Proteins | 41 | 2021 | 9622 | 1.200 |
Why?
|
Leukemia, Promyelocytic, Acute | 14 | 2021 | 232 | 1.160 |
Why?
|
Neoplasm Proteins | 21 | 2018 | 3694 | 1.120 |
Why?
|
CCAAT-Enhancer-Binding Protein-beta | 8 | 2019 | 103 | 1.100 |
Why?
|
Transcriptional Activation | 27 | 2021 | 1783 | 1.070 |
Why?
|
Mice | 155 | 2021 | 81002 | 1.040 |
Why?
|
Regulatory Sequences, Nucleic Acid | 10 | 2013 | 782 | 1.020 |
Why?
|
Base Sequence | 70 | 2021 | 12804 | 1.010 |
Why?
|
Monocytes | 25 | 2019 | 2583 | 1.000 |
Why?
|
Enhancer Elements, Genetic | 13 | 2021 | 1330 | 0.980 |
Why?
|
Myelopoiesis | 4 | 2020 | 130 | 0.950 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 20 | 2021 | 5154 | 0.940 |
Why?
|
Gene Expression Regulation, Neoplastic | 30 | 2021 | 8400 | 0.890 |
Why?
|
Animals | 195 | 2021 | 168368 | 0.890 |
Why?
|
Receptor, Macrophage Colony-Stimulating Factor | 14 | 2015 | 87 | 0.880 |
Why?
|
Mice, Transgenic | 46 | 2021 | 9734 | 0.870 |
Why?
|
DNA Methylation | 12 | 2019 | 4269 | 0.840 |
Why?
|
Fusion Proteins, bcr-abl | 7 | 2015 | 427 | 0.830 |
Why?
|
Lung Neoplasms | 30 | 2021 | 12985 | 0.830 |
Why?
|
Mice, Knockout | 40 | 2021 | 14558 | 0.800 |
Why?
|
Adult Stem Cells | 3 | 2015 | 215 | 0.790 |
Why?
|
Cell Line, Tumor | 49 | 2021 | 16646 | 0.790 |
Why?
|
Mutation | 56 | 2021 | 29658 | 0.750 |
Why?
|
Antineoplastic Agents | 24 | 2021 | 13635 | 0.730 |
Why?
|
RNA Editing | 6 | 2018 | 148 | 0.730 |
Why?
|
fms-Like Tyrosine Kinase 3 | 4 | 2014 | 493 | 0.720 |
Why?
|
Tumor Cells, Cultured | 36 | 2021 | 6310 | 0.720 |
Why?
|
Up-Regulation | 23 | 2020 | 4205 | 0.720 |
Why?
|
Glucose Transporter Type 3 | 1 | 2019 | 16 | 0.710 |
Why?
|
Neoplastic Stem Cells | 11 | 2021 | 1380 | 0.710 |
Why?
|
Proto-Oncogene Proteins c-jun | 9 | 2007 | 286 | 0.690 |
Why?
|
Transcription, Genetic | 38 | 2021 | 7709 | 0.690 |
Why?
|
U937 Cells | 16 | 2015 | 267 | 0.670 |
Why?
|
Carcinoma, Hepatocellular | 8 | 2021 | 2185 | 0.670 |
Why?
|
Leukopoiesis | 8 | 2017 | 55 | 0.650 |
Why?
|
Protein Binding | 36 | 2021 | 9375 | 0.630 |
Why?
|
Receptors, Colony-Stimulating Factor | 5 | 2020 | 49 | 0.630 |
Why?
|
Genes, abl | 3 | 2015 | 72 | 0.620 |
Why?
|
Lipoylation | 1 | 2018 | 64 | 0.620 |
Why?
|
Caveolin 1 | 1 | 2019 | 264 | 0.620 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 6 | 2018 | 281 | 0.610 |
Why?
|
Cell Line | 53 | 2021 | 15987 | 0.610 |
Why?
|
Molecular Sequence Data | 63 | 2015 | 18125 | 0.610 |
Why?
|
Tretinoin | 12 | 2015 | 513 | 0.600 |
Why?
|
K562 Cells | 14 | 2015 | 620 | 0.590 |
Why?
|
Cell Cycle | 12 | 2020 | 2960 | 0.590 |
Why?
|
Nuclear Proteins | 13 | 2015 | 5830 | 0.580 |
Why?
|
Translocation, Genetic | 17 | 2014 | 1416 | 0.560 |
Why?
|
Drug Resistance, Neoplasm | 12 | 2021 | 5148 | 0.560 |
Why?
|
Binding Sites | 36 | 2019 | 6113 | 0.560 |
Why?
|
Core Binding Factor beta Subunit | 4 | 2021 | 45 | 0.550 |
Why?
|
RNA, Messenger | 47 | 2017 | 13002 | 0.540 |
Why?
|
Down-Regulation | 21 | 2017 | 2999 | 0.540 |
Why?
|
Antigens, CD | 13 | 1994 | 4024 | 0.540 |
Why?
|
Liver Neoplasms | 9 | 2021 | 4216 | 0.530 |
Why?
|
Cell Transformation, Neoplastic | 15 | 2021 | 2936 | 0.530 |
Why?
|
Cell Proliferation | 20 | 2021 | 10455 | 0.530 |
Why?
|
Receptors, Granulocyte Colony-Stimulating Factor | 4 | 2002 | 21 | 0.520 |
Why?
|
Transfection | 24 | 2013 | 5884 | 0.520 |
Why?
|
p300-CBP Transcription Factors | 1 | 2016 | 147 | 0.520 |
Why?
|
CpG Islands | 1 | 2019 | 1163 | 0.510 |
Why?
|
HL-60 Cells | 12 | 2019 | 361 | 0.510 |
Why?
|
Core Binding Factor alpha Subunits | 1 | 2014 | 25 | 0.510 |
Why?
|
Neutrophils | 13 | 2019 | 3698 | 0.490 |
Why?
|
Signal Transduction | 23 | 2021 | 23355 | 0.490 |
Why?
|
Granulocyte Colony-Stimulating Factor | 7 | 2017 | 643 | 0.480 |
Why?
|
DNA | 27 | 2021 | 7275 | 0.480 |
Why?
|
SOXC Transcription Factors | 1 | 2013 | 40 | 0.470 |
Why?
|
Quinazolines | 14 | 2010 | 1356 | 0.460 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 2 | 2018 | 1116 | 0.460 |
Why?
|
Humans | 260 | 2021 | 739398 | 0.460 |
Why?
|
Fetal Stem Cells | 1 | 2013 | 10 | 0.460 |
Why?
|
Histones | 9 | 2021 | 2591 | 0.450 |
Why?
|
Fanconi Anemia | 1 | 2015 | 319 | 0.440 |
Why?
|
Mice, Inbred C57BL | 33 | 2021 | 21863 | 0.440 |
Why?
|
Gene Expression | 17 | 2021 | 7788 | 0.440 |
Why?
|
Protein Kinase Inhibitors | 12 | 2021 | 5502 | 0.430 |
Why?
|
Gene Expression Regulation, Developmental | 11 | 2017 | 3615 | 0.430 |
Why?
|
Cell Lineage | 17 | 2021 | 2486 | 0.430 |
Why?
|
Gene Expression Profiling | 26 | 2021 | 9387 | 0.430 |
Why?
|
RNA-Binding Proteins | 10 | 2018 | 1890 | 0.430 |
Why?
|
Cells, Cultured | 35 | 2021 | 19220 | 0.430 |
Why?
|
Luciferases | 7 | 2013 | 734 | 0.420 |
Why?
|
Liver | 12 | 2019 | 7449 | 0.420 |
Why?
|
Leukemia | 6 | 2019 | 1502 | 0.420 |
Why?
|
RNA, Untranslated | 2 | 2013 | 452 | 0.420 |
Why?
|
Myeloid Progenitor Cells | 8 | 2019 | 110 | 0.410 |
Why?
|
Bone Marrow Cells | 14 | 2017 | 2515 | 0.410 |
Why?
|
Adenosine Deaminase | 5 | 2018 | 239 | 0.410 |
Why?
|
Chromatin | 9 | 2021 | 2848 | 0.410 |
Why?
|
Sp1 Transcription Factor | 5 | 2017 | 144 | 0.410 |
Why?
|
Response Elements | 3 | 2018 | 310 | 0.400 |
Why?
|
CDC2 Protein Kinase | 1 | 2012 | 220 | 0.400 |
Why?
|
Erythroid Precursor Cells | 3 | 2019 | 217 | 0.400 |
Why?
|
Stem Cells | 7 | 2016 | 3566 | 0.390 |
Why?
|
Peptides | 4 | 2018 | 4395 | 0.390 |
Why?
|
Thermogenesis | 3 | 2021 | 428 | 0.390 |
Why?
|
Mice, SCID | 12 | 2021 | 2716 | 0.390 |
Why?
|
Apoptosis | 23 | 2021 | 9714 | 0.370 |
Why?
|
Serine | 6 | 2012 | 831 | 0.370 |
Why?
|
Chromatin Immunoprecipitation | 11 | 2017 | 888 | 0.370 |
Why?
|
Mice, Inbred NOD | 11 | 2021 | 1867 | 0.370 |
Why?
|
Simian virus 40 | 10 | 1985 | 295 | 0.360 |
Why?
|
B-Lymphocytes | 14 | 2021 | 4663 | 0.360 |
Why?
|
Chromosomes, Human, Pair 21 | 9 | 2014 | 230 | 0.360 |
Why?
|
Teratoma | 1 | 2012 | 386 | 0.360 |
Why?
|
Flow Cytometry | 16 | 2020 | 5959 | 0.350 |
Why?
|
GATA2 Transcription Factor | 5 | 2021 | 158 | 0.340 |
Why?
|
Dendritic Cells | 4 | 2019 | 2728 | 0.330 |
Why?
|
HEK293 Cells | 13 | 2021 | 4174 | 0.330 |
Why?
|
Neoplasm Transplantation | 8 | 2013 | 2084 | 0.330 |
Why?
|
Histone Deacetylase Inhibitors | 5 | 2019 | 788 | 0.330 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 17 | 2015 | 4743 | 0.320 |
Why?
|
Hematopoietic Stem Cell Mobilization | 3 | 2019 | 225 | 0.320 |
Why?
|
Oligonucleotide Array Sequence Analysis | 14 | 2013 | 3922 | 0.320 |
Why?
|
RNA, Antisense | 1 | 2008 | 139 | 0.310 |
Why?
|
Induced Pluripotent Stem Cells | 3 | 2015 | 1702 | 0.310 |
Why?
|
Adipocytes | 5 | 2020 | 1171 | 0.310 |
Why?
|
Proto-Oncogene Proteins c-myc | 5 | 2020 | 984 | 0.310 |
Why?
|
DNA Primers | 16 | 2009 | 2893 | 0.310 |
Why?
|
Azacitidine | 5 | 2015 | 344 | 0.310 |
Why?
|
Oleanolic Acid | 1 | 2007 | 43 | 0.310 |
Why?
|
COS Cells | 6 | 2020 | 1159 | 0.310 |
Why?
|
Neoplasms, Second Primary | 1 | 2015 | 1045 | 0.300 |
Why?
|
PPAR gamma | 2 | 2020 | 494 | 0.300 |
Why?
|
Lymphocytes | 4 | 2012 | 2612 | 0.300 |
Why?
|
Antigens, Differentiation | 4 | 1993 | 925 | 0.300 |
Why?
|
Cloning, Molecular | 17 | 2003 | 4319 | 0.300 |
Why?
|
Epigenesis, Genetic | 7 | 2018 | 3614 | 0.300 |
Why?
|
Quinazolinones | 2 | 2019 | 223 | 0.290 |
Why?
|
Gene Knockdown Techniques | 7 | 2021 | 1654 | 0.290 |
Why?
|
Chromosomes, Human, Pair 8 | 8 | 2014 | 463 | 0.290 |
Why?
|
Lysophospholipase | 5 | 1993 | 63 | 0.290 |
Why?
|
Histone Demethylases | 2 | 2021 | 311 | 0.290 |
Why?
|
Macrophage-1 Antigen | 6 | 2008 | 290 | 0.290 |
Why?
|
Blotting, Western | 17 | 2017 | 5181 | 0.290 |
Why?
|
Amino Acid Sequence | 27 | 2021 | 13816 | 0.280 |
Why?
|
Xenograft Model Antitumor Assays | 9 | 2021 | 3562 | 0.280 |
Why?
|
Genes, Reporter | 12 | 2015 | 1549 | 0.280 |
Why?
|
5' Flanking Region | 2 | 2002 | 31 | 0.280 |
Why?
|
Leukemia, Biphenotypic, Acute | 2 | 2018 | 35 | 0.280 |
Why?
|
Eosinophils | 10 | 1996 | 954 | 0.280 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2019 | 408 | 0.270 |
Why?
|
MicroRNAs | 8 | 2017 | 3712 | 0.270 |
Why?
|
Leukemia, Erythroblastic, Acute | 1 | 2006 | 188 | 0.270 |
Why?
|
Blood Proteins | 6 | 1993 | 1122 | 0.270 |
Why?
|
Zinc Fingers | 6 | 2021 | 581 | 0.260 |
Why?
|
Macrophages | 11 | 2019 | 5631 | 0.250 |
Why?
|
TCF Transcription Factors | 2 | 2020 | 140 | 0.250 |
Why?
|
Phosphorylation | 16 | 2020 | 8416 | 0.250 |
Why?
|
Neoplasms | 8 | 2021 | 21507 | 0.250 |
Why?
|
RNA, Small Interfering | 10 | 2017 | 3498 | 0.250 |
Why?
|
Hepatocyte Nuclear Factor 3-beta | 3 | 2012 | 67 | 0.250 |
Why?
|
Hematopoietic Stem Cell Transplantation | 8 | 2021 | 5401 | 0.250 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 5 | 2015 | 903 | 0.250 |
Why?
|
Chromosomes, Human, Pair 16 | 2 | 2021 | 357 | 0.250 |
Why?
|
Histone Acetyltransferases | 2 | 2017 | 336 | 0.240 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 3 | 1994 | 293 | 0.240 |
Why?
|
Pulmonary Alveoli | 2 | 2010 | 677 | 0.240 |
Why?
|
RNA, Double-Stranded | 2 | 2017 | 288 | 0.240 |
Why?
|
Point Mutation | 4 | 2006 | 1626 | 0.240 |
Why?
|
Protein-Arginine N-Methyltransferases | 2 | 2018 | 131 | 0.240 |
Why?
|
Colony-Forming Units Assay | 7 | 2008 | 354 | 0.230 |
Why?
|
Gene Silencing | 6 | 2018 | 1537 | 0.230 |
Why?
|
Recombinant Fusion Proteins | 16 | 2015 | 3770 | 0.230 |
Why?
|
CCAAT-Binding Factor | 3 | 2012 | 23 | 0.230 |
Why?
|
beta Catenin | 3 | 2020 | 1057 | 0.230 |
Why?
|
Cell Nucleus | 8 | 2020 | 2965 | 0.230 |
Why?
|
Oligodeoxyribonucleotides | 7 | 1994 | 708 | 0.230 |
Why?
|
RNA | 5 | 2021 | 2723 | 0.220 |
Why?
|
HeLa Cells | 14 | 2021 | 3119 | 0.220 |
Why?
|
Inosine | 3 | 2018 | 133 | 0.220 |
Why?
|
Acute Disease | 15 | 2018 | 7128 | 0.220 |
Why?
|
Chromosome Inversion | 2 | 2021 | 127 | 0.210 |
Why?
|
Methylation | 4 | 2019 | 1106 | 0.210 |
Why?
|
Genes, Regulator | 1 | 2003 | 378 | 0.210 |
Why?
|
Polymerase Chain Reaction | 14 | 2012 | 6174 | 0.210 |
Why?
|
Adenocarcinoma | 9 | 2016 | 6318 | 0.210 |
Why?
|
Mitogen-Activated Protein Kinases | 4 | 2003 | 1285 | 0.210 |
Why?
|
Proto-Oncogene Protein c-ets-1 | 2 | 2015 | 67 | 0.200 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 3 | 2011 | 494 | 0.200 |
Why?
|
Conserved Sequence | 2 | 2017 | 1203 | 0.200 |
Why?
|
RNA Processing, Post-Transcriptional | 3 | 2021 | 435 | 0.200 |
Why?
|
RNA Interference | 9 | 2018 | 2899 | 0.200 |
Why?
|
Molecular Targeted Therapy | 4 | 2021 | 2727 | 0.200 |
Why?
|
Oncogene Proteins | 2 | 2012 | 750 | 0.200 |
Why?
|
Telomerase | 2 | 2017 | 729 | 0.200 |
Why?
|
Cytokines | 3 | 2015 | 7298 | 0.200 |
Why?
|
Embryonic Stem Cells | 3 | 2021 | 1294 | 0.200 |
Why?
|
Neurotensin | 1 | 2021 | 61 | 0.200 |
Why?
|
Erythropoiesis | 2 | 2007 | 703 | 0.200 |
Why?
|
Growth Differentiation Factor 3 | 1 | 2020 | 11 | 0.190 |
Why?
|
Core Binding Factor Alpha 3 Subunit | 1 | 2021 | 56 | 0.190 |
Why?
|
Burkitt Lymphoma | 2 | 2021 | 329 | 0.190 |
Why?
|
Retroviridae Proteins, Oncogenic | 6 | 1996 | 76 | 0.190 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2008 | 1513 | 0.190 |
Why?
|
Hemopexin | 1 | 2020 | 33 | 0.190 |
Why?
|
Glycoproteins | 5 | 2004 | 2259 | 0.190 |
Why?
|
Immunoblotting | 4 | 2016 | 1683 | 0.190 |
Why?
|
Models, Biological | 11 | 2019 | 9609 | 0.190 |
Why?
|
Cell Cycle Proteins | 2 | 2003 | 3433 | 0.190 |
Why?
|
Adipocytes, Brown | 2 | 2018 | 139 | 0.190 |
Why?
|
Transcription Factor 7-Like 2 Protein | 1 | 2020 | 154 | 0.180 |
Why?
|
Megakaryocytes | 2 | 2006 | 542 | 0.180 |
Why?
|
Mice, Inbred Strains | 2 | 2013 | 1837 | 0.180 |
Why?
|
Obesity | 6 | 2020 | 12643 | 0.180 |
Why?
|
Bone Marrow | 9 | 2019 | 2933 | 0.180 |
Why?
|
Sequence Analysis, DNA | 5 | 2020 | 4791 | 0.180 |
Why?
|
Dementia, Vascular | 1 | 2021 | 127 | 0.180 |
Why?
|
Acetylation | 4 | 2016 | 1085 | 0.180 |
Why?
|
Genomic Structural Variation | 1 | 2020 | 65 | 0.180 |
Why?
|
Bone Marrow Transplantation | 6 | 2014 | 2759 | 0.180 |
Why?
|
Tetradecanoylphorbol Acetate | 7 | 1999 | 821 | 0.180 |
Why?
|
Regulatory Elements, Transcriptional | 3 | 2011 | 185 | 0.180 |
Why?
|
RNA, Neoplasm | 7 | 2005 | 761 | 0.180 |
Why?
|
Hydroxamic Acids | 3 | 2019 | 495 | 0.170 |
Why?
|
Sequence Homology, Nucleic Acid | 9 | 1999 | 1088 | 0.170 |
Why?
|
Cnidaria | 1 | 1999 | 14 | 0.170 |
Why?
|
Myosin Heavy Chains | 1 | 2021 | 416 | 0.170 |
Why?
|
Blotting, Northern | 10 | 2005 | 1583 | 0.170 |
Why?
|
Plasmids | 5 | 2008 | 2307 | 0.170 |
Why?
|
ras Proteins | 2 | 2002 | 1062 | 0.170 |
Why?
|
Ribonucleases | 4 | 1993 | 287 | 0.170 |
Why?
|
T-Lymphocytes | 11 | 2021 | 10142 | 0.170 |
Why?
|
Lung | 6 | 2019 | 9782 | 0.170 |
Why?
|
Transduction, Genetic | 5 | 2015 | 916 | 0.170 |
Why?
|
Restriction Mapping | 6 | 1998 | 879 | 0.170 |
Why?
|
Protein Stability | 1 | 2021 | 554 | 0.170 |
Why?
|
Retinoblastoma-Binding Protein 4 | 1 | 2018 | 12 | 0.170 |
Why?
|
Styrenes | 1 | 2018 | 23 | 0.170 |
Why?
|
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2017 | 110 | 0.170 |
Why?
|
Transplantation, Heterologous | 5 | 2015 | 2381 | 0.170 |
Why?
|
Epithelial Cells | 4 | 2021 | 3671 | 0.170 |
Why?
|
Basic-Leucine Zipper Transcription Factors | 1 | 2019 | 154 | 0.160 |
Why?
|
Heme | 1 | 2020 | 306 | 0.160 |
Why?
|
Interferon Regulatory Factors | 2 | 2018 | 268 | 0.160 |
Why?
|
Adenosine | 3 | 2018 | 819 | 0.160 |
Why?
|
Alkynes | 1 | 2019 | 310 | 0.160 |
Why?
|
Mice, Mutant Strains | 8 | 2006 | 1883 | 0.160 |
Why?
|
Membrane Glycoproteins | 5 | 2017 | 3768 | 0.160 |
Why?
|
Small Molecule Libraries | 2 | 2021 | 728 | 0.160 |
Why?
|
STAT5 Transcription Factor | 3 | 2014 | 262 | 0.160 |
Why?
|
Sequence Deletion | 6 | 2006 | 1528 | 0.160 |
Why?
|
Lysine | 3 | 2019 | 1005 | 0.160 |
Why?
|
Membrane Proteins | 8 | 2017 | 7862 | 0.160 |
Why?
|
Energy Metabolism | 5 | 2021 | 2896 | 0.150 |
Why?
|
Antigens, Viral | 7 | 1983 | 1033 | 0.150 |
Why?
|
Proto-Oncogene Proteins c-ets | 2 | 1998 | 318 | 0.150 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 1 | 2019 | 271 | 0.150 |
Why?
|
Histone-Lysine N-Methyltransferase | 4 | 2015 | 666 | 0.150 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 5 | 2010 | 452 | 0.150 |
Why?
|
Homeodomain Proteins | 4 | 2013 | 2409 | 0.150 |
Why?
|
Receptor, Notch1 | 2 | 2013 | 501 | 0.150 |
Why?
|
Adipocytes, White | 1 | 2018 | 89 | 0.150 |
Why?
|
Mast Cells | 5 | 2021 | 1542 | 0.150 |
Why?
|
Myostatin | 1 | 2018 | 124 | 0.150 |
Why?
|
Median Eminence | 1 | 2017 | 37 | 0.150 |
Why?
|
Mutant Proteins | 3 | 2008 | 500 | 0.150 |
Why?
|
Respiratory Insufficiency | 1 | 2006 | 1197 | 0.150 |
Why?
|
Thiazolidinediones | 1 | 2020 | 474 | 0.150 |
Why?
|
Cluster Analysis | 6 | 2014 | 2711 | 0.150 |
Why?
|
Receptors, Interleukin-6 | 1 | 1998 | 220 | 0.150 |
Why?
|
Protein Structure, Quaternary | 1 | 2018 | 437 | 0.150 |
Why?
|
Gene Expression Regulation, Enzymologic | 4 | 2017 | 1213 | 0.150 |
Why?
|
Quadriceps Muscle | 1 | 2018 | 142 | 0.150 |
Why?
|
Myeloproliferative Disorders | 1 | 2003 | 601 | 0.150 |
Why?
|
Structure-Activity Relationship | 7 | 2019 | 3146 | 0.150 |
Why?
|
Sequence Analysis, RNA | 7 | 2021 | 1994 | 0.150 |
Why?
|
STAT3 Transcription Factor | 1 | 2021 | 875 | 0.150 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 2 | 2013 | 515 | 0.150 |
Why?
|
Lymphatic Vessels | 1 | 2021 | 352 | 0.150 |
Why?
|
DNA, Neoplasm | 7 | 2005 | 1754 | 0.150 |
Why?
|
Creatine | 1 | 2019 | 422 | 0.150 |
Why?
|
GATA1 Transcription Factor | 4 | 2013 | 291 | 0.140 |
Why?
|
Interleukin-1beta | 2 | 2021 | 970 | 0.140 |
Why?
|
Repressor Proteins | 5 | 2019 | 3007 | 0.140 |
Why?
|
Gene Regulatory Networks | 4 | 2021 | 1706 | 0.140 |
Why?
|
DNA, Viral | 9 | 1985 | 2223 | 0.140 |
Why?
|
Carrier Proteins | 3 | 2013 | 5012 | 0.140 |
Why?
|
Sialoglycoproteins | 3 | 2016 | 318 | 0.140 |
Why?
|
Leukocyte Elastase | 1 | 2017 | 112 | 0.140 |
Why?
|
Multigene Family | 5 | 2015 | 1107 | 0.140 |
Why?
|
Male | 43 | 2021 | 349022 | 0.140 |
Why?
|
Chromatin Assembly Factor-1 | 1 | 2015 | 20 | 0.140 |
Why?
|
Cadherins | 1 | 2021 | 901 | 0.140 |
Why?
|
Blotting, Southern | 8 | 2011 | 803 | 0.140 |
Why?
|
Proto-Oncogene Protein c-ets-2 | 1 | 2015 | 16 | 0.140 |
Why?
|
Chromosomes, Human, Pair 19 | 3 | 1996 | 366 | 0.140 |
Why?
|
Proto-Oncogenes | 2 | 1996 | 321 | 0.140 |
Why?
|
Chromosome Mapping | 8 | 2014 | 4743 | 0.140 |
Why?
|
Chromatography, Liquid | 2 | 2019 | 977 | 0.140 |
Why?
|
High-Throughput Screening Assays | 2 | 2019 | 953 | 0.140 |
Why?
|
Stem Cell Niche | 1 | 2019 | 341 | 0.140 |
Why?
|
Coculture Techniques | 2 | 2021 | 1343 | 0.140 |
Why?
|
DNA Ligases | 1 | 2015 | 80 | 0.140 |
Why?
|
Antigens, Viral, Tumor | 3 | 1985 | 154 | 0.140 |
Why?
|
Adipose Tissue, Brown | 2 | 2019 | 754 | 0.130 |
Why?
|
Benzimidazoles | 1 | 2021 | 849 | 0.130 |
Why?
|
Interferon Regulatory Factor-3 | 1 | 2016 | 122 | 0.130 |
Why?
|
Multiprotein Complexes | 3 | 2019 | 1122 | 0.130 |
Why?
|
DEAD-box RNA Helicases | 1 | 2018 | 375 | 0.130 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2016 | 301 | 0.130 |
Why?
|
Herpesvirus 4, Human | 1 | 2021 | 1038 | 0.130 |
Why?
|
Leukemia, Myelomonocytic, Acute | 2 | 2021 | 39 | 0.130 |
Why?
|
Cell Division | 10 | 2009 | 4575 | 0.130 |
Why?
|
Cyclins | 3 | 2006 | 601 | 0.130 |
Why?
|
Immunoprecipitation | 2 | 2016 | 903 | 0.130 |
Why?
|
Protein Processing, Post-Translational | 4 | 2014 | 1991 | 0.130 |
Why?
|
Leukemia, Experimental | 1 | 2015 | 247 | 0.130 |
Why?
|
Interleukin-3 | 3 | 2006 | 441 | 0.130 |
Why?
|
Fanconi Anemia Complementation Group Proteins | 1 | 2015 | 100 | 0.130 |
Why?
|
Lymphopoiesis | 1 | 2015 | 132 | 0.130 |
Why?
|
Wnt Proteins | 3 | 2015 | 719 | 0.130 |
Why?
|
Pyrazines | 1 | 2021 | 1232 | 0.130 |
Why?
|
Genes, Dominant | 4 | 2007 | 883 | 0.130 |
Why?
|
Physical Conditioning, Animal | 1 | 2018 | 360 | 0.130 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2017 | 473 | 0.120 |
Why?
|
Nucleic Acid Hybridization | 7 | 1998 | 1372 | 0.120 |
Why?
|
Lysosomes | 1 | 2020 | 900 | 0.120 |
Why?
|
Protein Transport | 1 | 2020 | 1991 | 0.120 |
Why?
|
Metabolome | 1 | 2021 | 881 | 0.120 |
Why?
|
Integrins | 4 | 1995 | 845 | 0.120 |
Why?
|
Sequence Alignment | 6 | 2005 | 2256 | 0.120 |
Why?
|
Erythroid Cells | 3 | 2013 | 237 | 0.120 |
Why?
|
Base Pairing | 1 | 2014 | 143 | 0.120 |
Why?
|
Gene Deletion | 6 | 2017 | 2757 | 0.120 |
Why?
|
DNA Transposable Elements | 2 | 2015 | 749 | 0.120 |
Why?
|
Genes, Tumor Suppressor | 3 | 2017 | 1096 | 0.120 |
Why?
|
Chemotactic Factors | 1 | 1994 | 199 | 0.120 |
Why?
|
Chromosomes, Human, Pair 14 | 2 | 2011 | 300 | 0.120 |
Why?
|
Multipotent Stem Cells | 2 | 2013 | 185 | 0.120 |
Why?
|
Microtubules | 1 | 2020 | 1088 | 0.120 |
Why?
|
Introns | 5 | 2007 | 992 | 0.120 |
Why?
|
Genetic Techniques | 1 | 2017 | 436 | 0.120 |
Why?
|
Serine Proteinase Inhibitors | 1 | 1995 | 179 | 0.120 |
Why?
|
Proteomics | 5 | 2019 | 3584 | 0.120 |
Why?
|
Mass Spectrometry | 3 | 2019 | 2200 | 0.120 |
Why?
|
Disease Models, Animal | 9 | 2019 | 18003 | 0.120 |
Why?
|
Gene Library | 5 | 2002 | 1077 | 0.120 |
Why?
|
Oligonucleotide Probes | 2 | 1993 | 425 | 0.120 |
Why?
|
Genes, jun | 2 | 2003 | 71 | 0.120 |
Why?
|
Receptor, Notch2 | 1 | 2014 | 89 | 0.120 |
Why?
|
Protein Isoforms | 8 | 2014 | 1725 | 0.120 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 1674 | 0.120 |
Why?
|
Fetus | 4 | 2004 | 1877 | 0.120 |
Why?
|
3T3-L1 Cells | 4 | 2020 | 197 | 0.110 |
Why?
|
Receptors, Leukocyte-Adhesion | 2 | 1992 | 53 | 0.110 |
Why?
|
Eczema | 1 | 2015 | 225 | 0.110 |
Why?
|
Oxidation-Reduction | 1 | 2019 | 2184 | 0.110 |
Why?
|
Severe Combined Immunodeficiency | 1 | 2015 | 220 | 0.110 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2010 | 1157 | 0.110 |
Why?
|
Ubiquitination | 1 | 2018 | 1003 | 0.110 |
Why?
|
Luciferases, Renilla | 1 | 2012 | 22 | 0.110 |
Why?
|
Transcription Factor RelA | 1 | 2014 | 276 | 0.110 |
Why?
|
Calcitriol | 1 | 1994 | 298 | 0.110 |
Why?
|
E2F1 Transcription Factor | 2 | 2010 | 191 | 0.110 |
Why?
|
Glucose Transporter Type 4 | 2 | 2016 | 251 | 0.110 |
Why?
|
Enzyme Inhibitors | 2 | 2018 | 3802 | 0.110 |
Why?
|
Transgenes | 4 | 2009 | 1010 | 0.110 |
Why?
|
Genetic Vectors | 4 | 2013 | 3419 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-akt | 3 | 2018 | 2507 | 0.110 |
Why?
|
Interferon-gamma | 1 | 2021 | 3193 | 0.110 |
Why?
|
Lymphoid Tissue | 2 | 2013 | 455 | 0.110 |
Why?
|
Protein Biosynthesis | 3 | 2008 | 2131 | 0.110 |
Why?
|
Alternative Splicing | 2 | 2014 | 1117 | 0.110 |
Why?
|
Genes | 5 | 2010 | 1898 | 0.110 |
Why?
|
Graft Survival | 2 | 2021 | 3723 | 0.110 |
Why?
|
Neoplasms, Experimental | 1 | 2018 | 1280 | 0.110 |
Why?
|
Octamer Transcription Factor-1 | 2 | 2005 | 32 | 0.110 |
Why?
|
Killer Cells, Natural | 1 | 2021 | 2133 | 0.110 |
Why?
|
Oncogenes | 2 | 2019 | 1264 | 0.100 |
Why?
|
DNA Modification Methylases | 1 | 2012 | 206 | 0.100 |
Why?
|
E2F Transcription Factors | 2 | 2003 | 273 | 0.100 |
Why?
|
Tissue Donors | 1 | 2021 | 2205 | 0.100 |
Why?
|
DNA Mutational Analysis | 6 | 2012 | 4182 | 0.100 |
Why?
|
Phenotype | 8 | 2021 | 16301 | 0.100 |
Why?
|
Cell Culture Techniques | 1 | 2019 | 1662 | 0.100 |
Why?
|
Protein Structure, Tertiary | 6 | 2007 | 3848 | 0.100 |
Why?
|
Immunomagnetic Separation | 2 | 2008 | 80 | 0.100 |
Why?
|
Epigenomics | 1 | 2017 | 877 | 0.100 |
Why?
|
Microcephaly | 1 | 2015 | 429 | 0.100 |
Why?
|
Receptors, Interleukin | 3 | 1999 | 243 | 0.100 |
Why?
|
DNA Replication | 5 | 1985 | 1389 | 0.100 |
Why?
|
Female | 34 | 2021 | 378853 | 0.100 |
Why?
|
Intercellular Signaling Peptides and Proteins | 3 | 2011 | 1675 | 0.100 |
Why?
|
Mutagenesis, Site-Directed | 4 | 1996 | 1721 | 0.100 |
Why?
|
Heterozygote | 3 | 2003 | 2798 | 0.100 |
Why?
|
Milk Proteins | 2 | 2005 | 168 | 0.100 |
Why?
|
Cell Survival | 5 | 2019 | 5877 | 0.100 |
Why?
|
Chromosomes, Human, Pair 1 | 2 | 1992 | 657 | 0.100 |
Why?
|
E2F3 Transcription Factor | 1 | 2010 | 40 | 0.100 |
Why?
|
Candidiasis | 2 | 2020 | 365 | 0.100 |
Why?
|
Benzamides | 1 | 2016 | 1374 | 0.100 |
Why?
|
Substrate Specificity | 2 | 2013 | 1798 | 0.100 |
Why?
|
Alveolitis, Extrinsic Allergic | 1 | 2011 | 61 | 0.100 |
Why?
|
Receptor, Cannabinoid, CB2 | 1 | 2010 | 49 | 0.100 |
Why?
|
Inflammation | 5 | 2021 | 10534 | 0.090 |
Why?
|
NF-kappa B | 3 | 2016 | 2502 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 5 | 2018 | 6516 | 0.090 |
Why?
|
Growth Disorders | 1 | 2015 | 644 | 0.090 |
Why?
|
DNA Damage | 1 | 2020 | 2419 | 0.090 |
Why?
|
Nuclear Receptor Coactivator 2 | 1 | 2010 | 37 | 0.090 |
Why?
|
PTEN Phosphohydrolase | 2 | 2013 | 1142 | 0.090 |
Why?
|
Integrases | 1 | 2013 | 532 | 0.090 |
Why?
|
Lectins | 1 | 1993 | 517 | 0.090 |
Why?
|
Radiation Chimera | 2 | 2009 | 223 | 0.090 |
Why?
|
Inhibitor of Differentiation Protein 1 | 2 | 2007 | 47 | 0.090 |
Why?
|
Estradiol | 3 | 2017 | 2021 | 0.090 |
Why?
|
Erythroid-Specific DNA-Binding Factors | 3 | 2000 | 198 | 0.090 |
Why?
|
Myosins | 1 | 1991 | 408 | 0.090 |
Why?
|
Stromal Cells | 2 | 2012 | 1350 | 0.090 |
Why?
|
Endothelial Cells | 2 | 2021 | 3435 | 0.090 |
Why?
|
Glucose | 3 | 2019 | 4377 | 0.090 |
Why?
|
Peptidylprolyl Isomerase | 1 | 2010 | 105 | 0.090 |
Why?
|
RNA Splicing | 1 | 2014 | 904 | 0.090 |
Why?
|
Fatty Acids | 1 | 2018 | 1804 | 0.090 |
Why?
|
Insulin Resistance | 3 | 2020 | 3858 | 0.090 |
Why?
|
Phosphoproteins | 2 | 1989 | 2440 | 0.090 |
Why?
|
Adipose Tissue | 3 | 2020 | 3280 | 0.090 |
Why?
|
Iodide Peroxidase | 1 | 2011 | 293 | 0.090 |
Why?
|
Nitrophenols | 1 | 2010 | 172 | 0.090 |
Why?
|
Adenocarcinoma, Bronchiolo-Alveolar | 2 | 2006 | 91 | 0.090 |
Why?
|
Granulocyte Precursor Cells | 1 | 2009 | 43 | 0.090 |
Why?
|
Preleukemia | 1 | 2009 | 35 | 0.090 |
Why?
|
Calgranulin A | 1 | 2009 | 79 | 0.090 |
Why?
|
Interleukin-6 | 2 | 2015 | 3194 | 0.090 |
Why?
|
Anthelmintics | 1 | 1989 | 62 | 0.080 |
Why?
|
Peptide Mapping | 3 | 2006 | 263 | 0.080 |
Why?
|
Tumor Suppressor Proteins | 2 | 2019 | 2845 | 0.080 |
Why?
|
Heat-Shock Proteins | 1 | 1993 | 825 | 0.080 |
Why?
|
Immunotherapy | 2 | 2021 | 4391 | 0.080 |
Why?
|
Hydroxyprostaglandin Dehydrogenases | 1 | 2008 | 30 | 0.080 |
Why?
|
Cytotoxins | 1 | 1989 | 154 | 0.080 |
Why?
|
Metabolic Networks and Pathways | 1 | 2013 | 781 | 0.080 |
Why?
|
Keratinocytes | 1 | 2012 | 793 | 0.080 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2009 | 197 | 0.080 |
Why?
|
Fetal Blood | 3 | 2011 | 1315 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-kit | 2 | 2009 | 774 | 0.080 |
Why?
|
Genes, myb | 2 | 2015 | 18 | 0.080 |
Why?
|
Biomimetic Materials | 1 | 2010 | 180 | 0.080 |
Why?
|
Prognosis | 9 | 2017 | 28901 | 0.080 |
Why?
|
Genes, myc | 2 | 2021 | 399 | 0.080 |
Why?
|
Biological Transport | 3 | 2019 | 2118 | 0.080 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2007 | 15500 | 0.080 |
Why?
|
Mutation, Missense | 2 | 2015 | 2552 | 0.080 |
Why?
|
SUMO-1 Protein | 1 | 2007 | 35 | 0.080 |
Why?
|
Receptors, Estrogen | 3 | 2007 | 2183 | 0.080 |
Why?
|
Models, Theoretical | 1 | 2020 | 3609 | 0.080 |
Why?
|
Blast Crisis | 2 | 2006 | 104 | 0.080 |
Why?
|
Genome, Human | 2 | 2013 | 4419 | 0.080 |
Why?
|
Receptors, Lymphocyte Homing | 1 | 2007 | 143 | 0.080 |
Why?
|
Kruppel-Like Transcription Factors | 3 | 2007 | 502 | 0.080 |
Why?
|
Leukocytes | 2 | 1995 | 2035 | 0.080 |
Why?
|
Gene Knock-In Techniques | 2 | 2021 | 417 | 0.070 |
Why?
|
Thymus Gland | 2 | 2017 | 1263 | 0.070 |
Why?
|
Proteins | 2 | 2021 | 6082 | 0.070 |
Why?
|
Antigens, Surface | 2 | 1990 | 1667 | 0.070 |
Why?
|
Endometrial Neoplasms | 2 | 2013 | 1351 | 0.070 |
Why?
|
Nucleic Acid Conformation | 4 | 2007 | 913 | 0.070 |
Why?
|
Blood Cells | 1 | 2009 | 309 | 0.070 |
Why?
|
Genetic Testing | 1 | 2020 | 3441 | 0.070 |
Why?
|
DNA, Complementary | 5 | 2007 | 2049 | 0.070 |
Why?
|
Organ Specificity | 5 | 2005 | 2004 | 0.070 |
Why?
|
Electroporation | 1 | 2008 | 250 | 0.070 |
Why?
|
Stomach Neoplasms | 1 | 2016 | 1318 | 0.070 |
Why?
|
Eukaryotic Initiation Factor-4E | 1 | 2007 | 106 | 0.070 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2012 | 721 | 0.070 |
Why?
|
Animals, Congenic | 1 | 2006 | 27 | 0.070 |
Why?
|
Jurkat Cells | 1 | 2008 | 740 | 0.070 |
Why?
|
Janus Kinase 2 | 1 | 2010 | 527 | 0.070 |
Why?
|
Zinc Sulfate | 2 | 2006 | 17 | 0.070 |
Why?
|
Stathmin | 1 | 2006 | 71 | 0.070 |
Why?
|
Ubiquitin-Conjugating Enzymes | 1 | 2007 | 193 | 0.070 |
Why?
|
Leukemia-Lymphoma, Adult T-Cell | 1 | 2007 | 166 | 0.070 |
Why?
|
Eukaryotic Initiation Factor-2 | 1 | 2007 | 189 | 0.070 |
Why?
|
Disease Progression | 8 | 2020 | 13237 | 0.070 |
Why?
|
Tetracycline | 2 | 2003 | 214 | 0.070 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 2007 | 265 | 0.070 |
Why?
|
Models, Genetic | 5 | 2008 | 3493 | 0.070 |
Why?
|
Genetic Association Studies | 1 | 2015 | 2694 | 0.070 |
Why?
|
Activating Transcription Factor 2 | 1 | 2005 | 46 | 0.070 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2009 | 664 | 0.070 |
Why?
|
bcl-2-Associated X Protein | 1 | 2007 | 293 | 0.070 |
Why?
|
Peroxidase | 1 | 1989 | 608 | 0.070 |
Why?
|
Biphenyl Compounds | 1 | 2010 | 909 | 0.070 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2018 | 2901 | 0.070 |
Why?
|
Genotype | 4 | 2011 | 12951 | 0.070 |
Why?
|
Phylogeny | 1 | 1993 | 2789 | 0.070 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2008 | 435 | 0.070 |
Why?
|
Receptors, Retinoic Acid | 3 | 2015 | 232 | 0.070 |
Why?
|
Respiratory System | 1 | 2008 | 553 | 0.070 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2017 | 2012 | 0.060 |
Why?
|
Transcription Factor AP-1 | 2 | 2003 | 316 | 0.060 |
Why?
|
Karyotyping | 2 | 2004 | 1241 | 0.060 |
Why?
|
Genome | 1 | 2013 | 1794 | 0.060 |
Why?
|
Biolistics | 1 | 2004 | 19 | 0.060 |
Why?
|
Chromosomes, Human, Pair 3 | 2 | 1996 | 323 | 0.060 |
Why?
|
Pyridines | 1 | 2016 | 2810 | 0.060 |
Why?
|
Genes, erbB-1 | 1 | 2005 | 161 | 0.060 |
Why?
|
Drug Screening Assays, Antitumor | 2 | 2019 | 740 | 0.060 |
Why?
|
Stress, Physiological | 1 | 2012 | 1405 | 0.060 |
Why?
|
Polymorphism, Genetic | 1 | 2015 | 4332 | 0.060 |
Why?
|
Mutagenesis, Insertional | 3 | 2015 | 656 | 0.060 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2005 | 374 | 0.060 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2006 | 316 | 0.060 |
Why?
|
Virus Replication | 4 | 1993 | 2529 | 0.060 |
Why?
|
Macrophage Activation | 2 | 2007 | 558 | 0.060 |
Why?
|
Exons | 5 | 2014 | 2430 | 0.060 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2006 | 338 | 0.060 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2005 | 438 | 0.060 |
Why?
|
Spleen | 3 | 2005 | 2359 | 0.060 |
Why?
|
Receptors, Polymeric Immunoglobulin | 1 | 2003 | 4 | 0.060 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2021 | 11410 | 0.060 |
Why?
|
Peroxidases | 2 | 1994 | 138 | 0.060 |
Why?
|
Receptors, Neurotransmitter | 1 | 2004 | 178 | 0.060 |
Why?
|
Blood Cell Count | 1 | 2004 | 401 | 0.060 |
Why?
|
Aged | 15 | 2020 | 162698 | 0.060 |
Why?
|
Adult | 16 | 2016 | 213394 | 0.060 |
Why?
|
Cell Movement | 3 | 2011 | 5221 | 0.060 |
Why?
|
Thymidine Kinase | 2 | 2006 | 292 | 0.060 |
Why?
|
Eosinophil Granule Proteins | 3 | 1993 | 30 | 0.060 |
Why?
|
Tissue Distribution | 4 | 2011 | 2345 | 0.060 |
Why?
|
Ribosomal Proteins | 2 | 1996 | 358 | 0.060 |
Why?
|
Cell Line, Transformed | 3 | 2004 | 897 | 0.060 |
Why?
|
Deoxyribonuclease I | 2 | 2001 | 228 | 0.060 |
Why?
|
Immunohistochemistry | 5 | 2013 | 11347 | 0.060 |
Why?
|
Thrombocytosis | 1 | 2003 | 81 | 0.060 |
Why?
|
Lymphoma, T-Cell | 1 | 2005 | 299 | 0.060 |
Why?
|
G1 Phase | 2 | 2021 | 414 | 0.060 |
Why?
|
3' Flanking Region | 1 | 2002 | 15 | 0.060 |
Why?
|
Sequence Homology, Amino Acid | 4 | 2003 | 2833 | 0.060 |
Why?
|
CDC2-CDC28 Kinases | 1 | 2003 | 113 | 0.060 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2006 | 266 | 0.060 |
Why?
|
Splenomegaly | 1 | 2003 | 190 | 0.060 |
Why?
|
Enzyme Activation | 2 | 2006 | 3701 | 0.060 |
Why?
|
Genomic Library | 2 | 1993 | 192 | 0.050 |
Why?
|
Genes, Synthetic | 2 | 2000 | 90 | 0.050 |
Why?
|
Avian Sarcoma Viruses | 2 | 1992 | 84 | 0.050 |
Why?
|
Cyclin A | 1 | 2002 | 60 | 0.050 |
Why?
|
Blood Coagulation | 1 | 1988 | 1122 | 0.050 |
Why?
|
Middle Aged | 16 | 2020 | 212863 | 0.050 |
Why?
|
Immunoglobulins | 2 | 2015 | 881 | 0.050 |
Why?
|
Cell Transformation, Viral | 2 | 1988 | 565 | 0.050 |
Why?
|
Antisense Elements (Genetics) | 1 | 2021 | 37 | 0.050 |
Why?
|
Yolk Sac | 2 | 2019 | 75 | 0.050 |
Why?
|
Multiple Myeloma | 3 | 2009 | 5147 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3143 | 0.050 |
Why?
|
Macrophage Colony-Stimulating Factor | 2 | 2010 | 186 | 0.050 |
Why?
|
Leucine Zippers | 4 | 2003 | 117 | 0.050 |
Why?
|
Cholecalciferol | 1 | 2007 | 534 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3248 | 0.050 |
Why?
|
Calpain | 1 | 2002 | 150 | 0.050 |
Why?
|
Retinoblastoma-Binding Protein 1 | 1 | 2001 | 142 | 0.050 |
Why?
|
Transcription Factor DP1 | 1 | 2001 | 141 | 0.050 |
Why?
|
Zebrafish | 2 | 2017 | 2980 | 0.050 |
Why?
|
Transforming Growth Factor beta | 2 | 2020 | 1997 | 0.050 |
Why?
|
Lymphatic Diseases | 1 | 2003 | 324 | 0.050 |
Why?
|
Langerhans Cells | 1 | 2002 | 173 | 0.050 |
Why?
|
Molecular Weight | 4 | 1992 | 2257 | 0.050 |
Why?
|
Microscopy | 1 | 2006 | 899 | 0.050 |
Why?
|
Epithelium | 1 | 2006 | 1684 | 0.050 |
Why?
|
Computer Systems | 1 | 2002 | 484 | 0.050 |
Why?
|
RNA Polymerase II | 3 | 2012 | 551 | 0.050 |
Why?
|
Single-Cell Analysis | 2 | 2021 | 2141 | 0.050 |
Why?
|
Multiple Sclerosis | 1 | 2015 | 3065 | 0.050 |
Why?
|
Osteopontin | 2 | 1994 | 295 | 0.050 |
Why?
|
Tumor Burden | 2 | 2021 | 1904 | 0.050 |
Why?
|
Mice, Obese | 1 | 2021 | 425 | 0.050 |
Why?
|
Sulfonamides | 1 | 2010 | 1934 | 0.050 |
Why?
|
Alzheimer Disease | 1 | 2021 | 7975 | 0.050 |
Why?
|
Smad Proteins | 1 | 2020 | 162 | 0.050 |
Why?
|
Rats | 9 | 2007 | 24270 | 0.040 |
Why?
|
DNA Probes | 2 | 1992 | 561 | 0.040 |
Why?
|
Receptors, Androgen | 1 | 2006 | 1049 | 0.040 |
Why?
|
Neurotoxins | 2 | 1992 | 237 | 0.040 |
Why?
|
Alanine | 1 | 2002 | 578 | 0.040 |
Why?
|
Antibodies, Neutralizing | 2 | 2020 | 1957 | 0.040 |
Why?
|
Automation, Laboratory | 1 | 2020 | 99 | 0.040 |
Why?
|
Kininogens | 1 | 2019 | 19 | 0.040 |
Why?
|
Extracellular Matrix Proteins | 1 | 2004 | 847 | 0.040 |
Why?
|
Urokinase-Type Plasminogen Activator | 1 | 2020 | 337 | 0.040 |
Why?
|
Piperazines | 2 | 2010 | 2480 | 0.040 |
Why?
|
Bacterial Proteins | 1 | 1993 | 3866 | 0.040 |
Why?
|
Lymphocyte Depletion | 1 | 2021 | 609 | 0.040 |
Why?
|
Molecular Structure | 2 | 2019 | 1925 | 0.040 |
Why?
|
Locus Control Region | 1 | 1998 | 20 | 0.040 |
Why?
|
DNA Footprinting | 2 | 1995 | 98 | 0.040 |
Why?
|
Deamination | 1 | 2018 | 26 | 0.040 |
Why?
|
HCT116 Cells | 1 | 2020 | 409 | 0.040 |
Why?
|
Protein Array Analysis | 1 | 2021 | 411 | 0.040 |
Why?
|
Prostatic Neoplasms | 2 | 2020 | 10999 | 0.040 |
Why?
|
Basophils | 1 | 2021 | 388 | 0.040 |
Why?
|
Azepines | 1 | 2021 | 335 | 0.040 |
Why?
|
Gene Fusion | 1 | 2021 | 371 | 0.040 |
Why?
|
Disease-Free Survival | 4 | 2013 | 6871 | 0.040 |
Why?
|
Thermosensing | 1 | 2018 | 57 | 0.040 |
Why?
|
Receptors, Cell Surface | 1 | 1988 | 2864 | 0.040 |
Why?
|
G-Quadruplexes | 1 | 2020 | 158 | 0.040 |
Why?
|
Collagenases | 1 | 1999 | 227 | 0.040 |
Why?
|
Haplorhini | 1 | 1999 | 558 | 0.040 |
Why?
|
Biochemistry | 1 | 1999 | 113 | 0.040 |
Why?
|
Amino Acid Motifs | 1 | 2021 | 940 | 0.040 |
Why?
|
Forecasting | 2 | 2021 | 2952 | 0.040 |
Why?
|
Immunization, Passive | 1 | 2020 | 625 | 0.040 |
Why?
|
Adipogenesis | 1 | 2020 | 356 | 0.040 |
Why?
|
Feedback, Physiological | 2 | 2011 | 478 | 0.040 |
Why?
|
Candida albicans | 1 | 2020 | 392 | 0.040 |
Why?
|
Intestine, Small | 1 | 2004 | 1242 | 0.040 |
Why?
|
GATA3 Transcription Factor | 1 | 2018 | 157 | 0.040 |
Why?
|
Neurons | 1 | 2017 | 9336 | 0.040 |
Why?
|
Genetic Variation | 1 | 1993 | 6539 | 0.040 |
Why?
|
Protein Kinase C | 1 | 2002 | 1223 | 0.040 |
Why?
|
Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2018 | 140 | 0.040 |
Why?
|
Oxidative Phosphorylation | 1 | 2019 | 479 | 0.040 |
Why?
|
Amino Acid Substitution | 1 | 2002 | 1793 | 0.040 |
Why?
|
Drug Delivery Systems | 1 | 2008 | 2220 | 0.040 |
Why?
|
Glycolysis | 1 | 2021 | 825 | 0.040 |
Why?
|
Octamer Transcription Factor-2 | 1 | 1996 | 7 | 0.040 |
Why?
|
Blood Platelets | 1 | 2007 | 2506 | 0.040 |
Why?
|
Neoplasm Metastasis | 2 | 2020 | 4832 | 0.040 |
Why?
|
Solubility | 1 | 1998 | 1083 | 0.040 |
Why?
|
Antibodies, Monoclonal | 4 | 2009 | 9259 | 0.040 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2019 | 449 | 0.040 |
Why?
|
Proteome | 1 | 2006 | 1772 | 0.040 |
Why?
|
Crosses, Genetic | 3 | 2005 | 799 | 0.040 |
Why?
|
Host Cell Factor C1 | 1 | 1996 | 31 | 0.040 |
Why?
|
Peptide Fragments | 3 | 2017 | 5076 | 0.040 |
Why?
|
Agouti-Related Protein | 1 | 2017 | 98 | 0.040 |
Why?
|
Glutathione | 1 | 2019 | 585 | 0.040 |
Why?
|
Prostate-Specific Antigen | 1 | 2006 | 2441 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 3 | 2015 | 17384 | 0.040 |
Why?
|
Alleles | 3 | 2020 | 6942 | 0.040 |
Why?
|
Antigens, Ly | 1 | 2017 | 292 | 0.030 |
Why?
|
Pro-Opiomelanocortin | 1 | 2017 | 163 | 0.030 |
Why?
|
Receptors, Glucocorticoid | 1 | 2018 | 302 | 0.030 |
Why?
|
Immunoglobulin G | 2 | 2020 | 4522 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 1999 | 576 | 0.030 |
Why?
|
Integrin alphaXbeta2 | 1 | 1995 | 29 | 0.030 |
Why?
|
Microglia | 1 | 2004 | 1248 | 0.030 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2006 | 3757 | 0.030 |
Why?
|
Toll-Like Receptor 3 | 1 | 2016 | 91 | 0.030 |
Why?
|
NIH 3T3 Cells | 2 | 2009 | 677 | 0.030 |
Why?
|
Recombinant Proteins | 6 | 2008 | 6610 | 0.030 |
Why?
|
Quality Control | 1 | 1999 | 842 | 0.030 |
Why?
|
Glucose Clamp Technique | 1 | 2016 | 266 | 0.030 |
Why?
|
NF-kappa B p52 Subunit | 1 | 2015 | 35 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2009 | 364 | 0.030 |
Why?
|
Tumor Necrosis Factors | 1 | 2015 | 109 | 0.030 |
Why?
|
Cell Growth Processes | 2 | 2007 | 399 | 0.030 |
Why?
|
Cytoplasmic Granules | 1 | 1998 | 610 | 0.030 |
Why?
|
3' Untranslated Regions | 1 | 2017 | 508 | 0.030 |
Why?
|
Subcutaneous Fat | 1 | 2019 | 392 | 0.030 |
Why?
|
Gene Targeting | 1 | 2019 | 886 | 0.030 |
Why?
|
Hydrogen Peroxide | 1 | 2019 | 730 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2002 | 1820 | 0.030 |
Why?
|
Image Enhancement | 1 | 2006 | 2928 | 0.030 |
Why?
|
Treatment Outcome | 7 | 2020 | 62693 | 0.030 |
Why?
|
Species Specificity | 3 | 2005 | 2480 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor C | 1 | 2015 | 127 | 0.030 |
Why?
|
Facies | 1 | 2015 | 195 | 0.030 |
Why?
|
Triazoles | 1 | 2021 | 906 | 0.030 |
Why?
|
Core Binding Factors | 1 | 1994 | 31 | 0.030 |
Why?
|
Dimerization | 2 | 2007 | 892 | 0.030 |
Why?
|
Reference Standards | 1 | 1999 | 1018 | 0.030 |
Why?
|
Fetal Death | 1 | 1997 | 446 | 0.030 |
Why?
|
Somatostatin | 1 | 2017 | 460 | 0.030 |
Why?
|
Microscopy, Electron | 1 | 2018 | 2665 | 0.030 |
Why?
|
Mice, Nude | 3 | 2009 | 3692 | 0.030 |
Why?
|
Thionucleotides | 1 | 1994 | 107 | 0.030 |
Why?
|
Transcription Factor AP-2 | 1 | 1994 | 82 | 0.030 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 2 | 2006 | 278 | 0.030 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 1997 | 547 | 0.030 |
Why?
|
Immunoglobulin Variable Region | 1 | 2015 | 423 | 0.030 |
Why?
|
Cold Temperature | 1 | 2018 | 775 | 0.030 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2018 | 689 | 0.030 |
Why?
|
Cell Separation | 2 | 2011 | 1739 | 0.030 |
Why?
|
Codon | 1 | 2016 | 613 | 0.030 |
Why?
|
Mutagenesis | 2 | 1998 | 1265 | 0.030 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 1 | 1995 | 377 | 0.030 |
Why?
|
Kinetics | 4 | 2005 | 6475 | 0.030 |
Why?
|
Probability | 1 | 2020 | 2500 | 0.030 |
Why?
|
Neoplasm Staging | 4 | 2011 | 10961 | 0.030 |
Why?
|
Drug Synergism | 1 | 1998 | 1792 | 0.030 |
Why?
|
Workflow | 1 | 2019 | 831 | 0.030 |
Why?
|
China | 1 | 2020 | 2225 | 0.030 |
Why?
|
Core Binding Factor Alpha 1 Subunit | 1 | 1994 | 164 | 0.030 |
Why?
|
Sequence Homology | 1 | 2014 | 203 | 0.030 |
Why?
|
Immunoglobulin Class Switching | 1 | 2015 | 291 | 0.030 |
Why?
|
Muscular Diseases | 1 | 2018 | 555 | 0.030 |
Why?
|
DNA, Single-Stranded | 1 | 1995 | 351 | 0.030 |
Why?
|
Neutrophil Activation | 1 | 1994 | 186 | 0.030 |
Why?
|
beta-Galactosidase | 1 | 1995 | 572 | 0.030 |
Why?
|
Genes, Homeobox | 1 | 2015 | 287 | 0.030 |
Why?
|
Cytidine Deaminase | 1 | 2015 | 247 | 0.030 |
Why?
|
Hybrid Cells | 2 | 1992 | 441 | 0.030 |
Why?
|
Acyltransferases | 1 | 2015 | 290 | 0.030 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2006 | 3344 | 0.030 |
Why?
|
Heterochromatin | 1 | 2015 | 293 | 0.030 |
Why?
|
Receptors, Interleukin-5 | 3 | 1999 | 19 | 0.030 |
Why?
|
Capillary Permeability | 1 | 2017 | 799 | 0.030 |
Why?
|
Leukemia, Monocytic, Acute | 1 | 2013 | 58 | 0.030 |
Why?
|
Membrane Transport Proteins | 1 | 2019 | 1028 | 0.030 |
Why?
|
HIV Long Terminal Repeat | 1 | 1993 | 88 | 0.030 |
Why?
|
RNA Splice Sites | 1 | 2014 | 209 | 0.030 |
Why?
|
Ornithine Decarboxylase | 1 | 2013 | 63 | 0.030 |
Why?
|
Binding, Competitive | 1 | 1994 | 1158 | 0.030 |
Why?
|
Imaging, Three-Dimensional | 1 | 2006 | 4035 | 0.030 |
Why?
|
Toll-Like Receptor 4 | 1 | 2016 | 560 | 0.030 |
Why?
|
Chaperonin 60 | 1 | 1993 | 103 | 0.030 |
Why?
|
Histone Deacetylase 2 | 1 | 2013 | 74 | 0.030 |
Why?
|
Gene Order | 1 | 2013 | 175 | 0.030 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 1994 | 404 | 0.030 |
Why?
|
Adenosine Triphosphate | 1 | 2019 | 2022 | 0.030 |
Why?
|
Remission Induction | 2 | 2003 | 2378 | 0.030 |
Why?
|
RNA Probes | 1 | 1992 | 112 | 0.030 |
Why?
|
Histone Deacetylase 1 | 1 | 2013 | 136 | 0.030 |
Why?
|
Cyclin-Dependent Kinase 4 | 2 | 2007 | 528 | 0.030 |
Why?
|
Nucleosomes | 1 | 2015 | 488 | 0.030 |
Why?
|
Receptors, Calcitriol | 1 | 1994 | 350 | 0.030 |
Why?
|
Pluripotent Stem Cells | 1 | 2019 | 791 | 0.030 |
Why?
|
Immunoglobulin A | 1 | 2015 | 989 | 0.030 |
Why?
|
Chemokine CCL2 | 1 | 1994 | 618 | 0.030 |
Why?
|
Doxorubicin | 1 | 2018 | 2218 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2019 | 10945 | 0.030 |
Why?
|
Oxygen Consumption | 1 | 2018 | 1871 | 0.030 |
Why?
|
Phenylurea Compounds | 1 | 2015 | 524 | 0.030 |
Why?
|
Homeostasis | 2 | 2016 | 3348 | 0.030 |
Why?
|
Cyclin-Dependent Kinases | 2 | 2006 | 670 | 0.020 |
Why?
|
tau Proteins | 1 | 2021 | 1861 | 0.020 |
Why?
|
Tandem Repeat Sequences | 1 | 2012 | 186 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2019 | 2084 | 0.020 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2013 | 437 | 0.020 |
Why?
|
Sensitivity and Specificity | 3 | 2020 | 14740 | 0.020 |
Why?
|
Tacrolimus | 1 | 2015 | 739 | 0.020 |
Why?
|
Galectin 3 | 1 | 1993 | 226 | 0.020 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2015 | 588 | 0.020 |
Why?
|
Hematology | 1 | 2014 | 217 | 0.020 |
Why?
|
Histone Deacetylases | 2 | 2006 | 729 | 0.020 |
Why?
|
Gene Duplication | 1 | 2012 | 330 | 0.020 |
Why?
|
Cyclin D1 | 1 | 2013 | 462 | 0.020 |
Why?
|
Electricity | 1 | 1991 | 182 | 0.020 |
Why?
|
Ionomycin | 1 | 1990 | 109 | 0.020 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 1991 | 351 | 0.020 |
Why?
|
Carboplatin | 1 | 2013 | 800 | 0.020 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2012 | 260 | 0.020 |
Why?
|
Disease Outbreaks | 1 | 2020 | 1779 | 0.020 |
Why?
|
Leukocyte-Adhesion Deficiency Syndrome | 1 | 1990 | 21 | 0.020 |
Why?
|
Time Factors | 6 | 2011 | 40050 | 0.020 |
Why?
|
Cyclohexanols | 1 | 2010 | 127 | 0.020 |
Why?
|
Cycloheximide | 1 | 1990 | 347 | 0.020 |
Why?
|
Survival Analysis | 3 | 2011 | 10247 | 0.020 |
Why?
|
Lentivirus | 1 | 2013 | 501 | 0.020 |
Why?
|
Colony-Stimulating Factors | 1 | 2010 | 216 | 0.020 |
Why?
|
Interferon Regulatory Factor-7 | 1 | 2009 | 38 | 0.020 |
Why?
|
Oligonucleotides | 1 | 1993 | 572 | 0.020 |
Why?
|
Piperidines | 2 | 2009 | 1597 | 0.020 |
Why?
|
Immunoglobulin E | 1 | 2015 | 1461 | 0.020 |
Why?
|
Cathepsin G | 1 | 2009 | 32 | 0.020 |
Why?
|
Chickens | 1 | 1991 | 864 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2020 | 3151 | 0.020 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2011 | 765 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2020 | 2560 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2021 | 8605 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2021 | 3571 | 0.020 |
Why?
|
Leptin | 1 | 2017 | 1589 | 0.020 |
Why?
|
Receptors, Fibronectin | 1 | 1988 | 39 | 0.020 |
Why?
|
Pneumonia | 1 | 2020 | 2102 | 0.020 |
Why?
|
Adoptive Transfer | 1 | 2011 | 845 | 0.020 |
Why?
|
Receptors, Vitronectin | 1 | 1988 | 53 | 0.020 |
Why?
|
Isotope Labeling | 1 | 1990 | 415 | 0.020 |
Why?
|
Polycythemia Vera | 1 | 2010 | 163 | 0.020 |
Why?
|
Ribonucleoproteins | 1 | 2011 | 380 | 0.020 |
Why?
|
Cannabinoids | 1 | 2010 | 167 | 0.020 |
Why?
|
Cathepsins | 1 | 2009 | 237 | 0.020 |
Why?
|
Filgrastim | 1 | 2008 | 132 | 0.020 |
Why?
|
Retinoid X Receptors | 1 | 2007 | 92 | 0.020 |
Why?
|
Leukapheresis | 1 | 2008 | 131 | 0.020 |
Why?
|
Lipopolysaccharides | 2 | 2010 | 2208 | 0.020 |
Why?
|
Animals, Newborn | 2 | 2004 | 2732 | 0.020 |
Why?
|
Clone Cells | 2 | 2006 | 1685 | 0.020 |
Why?
|
Precipitin Tests | 2 | 1999 | 829 | 0.020 |
Why?
|
Thiazoles | 1 | 2015 | 1488 | 0.020 |
Why?
|
Antigens, Neoplasm | 1 | 1975 | 1977 | 0.020 |
Why?
|
Plicamycin | 1 | 2007 | 13 | 0.020 |
Why?
|
Critical Illness | 1 | 2020 | 2656 | 0.020 |
Why?
|
Hematopoietic System | 1 | 2007 | 108 | 0.020 |
Why?
|
Blood Glucose | 2 | 2016 | 6237 | 0.020 |
Why?
|
Drug Design | 1 | 2013 | 1088 | 0.020 |
Why?
|
Adolescent | 4 | 2014 | 85405 | 0.020 |
Why?
|
Gene Dosage | 1 | 2012 | 1251 | 0.020 |
Why?
|
Cytomegalovirus | 1 | 1991 | 719 | 0.020 |
Why?
|
Luminescent Proteins | 1 | 2010 | 853 | 0.020 |
Why?
|
Cyclin D | 1 | 2006 | 70 | 0.020 |
Why?
|
Biological Evolution | 1 | 1993 | 1072 | 0.020 |
Why?
|
Cohort Studies | 3 | 2020 | 40389 | 0.020 |
Why?
|
Templates, Genetic | 1 | 2007 | 211 | 0.020 |
Why?
|
Transplantation, Autologous | 1 | 1992 | 2119 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2020 | 3672 | 0.020 |
Why?
|
Adiposity | 1 | 2016 | 1801 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2020 | 19811 | 0.020 |
Why?
|
Trichinella | 1 | 2005 | 6 | 0.020 |
Why?
|
Calcium-Binding Proteins | 1 | 2011 | 1078 | 0.020 |
Why?
|
Guinea Pigs | 1 | 1988 | 1387 | 0.020 |
Why?
|
Poly C | 1 | 2005 | 7 | 0.020 |
Why?
|
Poly I | 1 | 2005 | 5 | 0.020 |
Why?
|
Cyclin D3 | 1 | 2005 | 55 | 0.020 |
Why?
|
Thrombin | 1 | 1988 | 595 | 0.020 |
Why?
|
Cytogenetics | 1 | 2006 | 203 | 0.020 |
Why?
|
Phosphoenolpyruvate Carboxykinase (ATP) | 1 | 2005 | 14 | 0.020 |
Why?
|
CCAAT-Enhancer-Binding Protein-delta | 1 | 2005 | 27 | 0.020 |
Why?
|
Glucose-6-Phosphate | 1 | 2005 | 30 | 0.020 |
Why?
|
Glucose-6-Phosphatase | 1 | 2005 | 73 | 0.020 |
Why?
|
Algorithms | 1 | 2006 | 13872 | 0.020 |
Why?
|
DNA, Circular | 2 | 1976 | 95 | 0.020 |
Why?
|
Hot Temperature | 3 | 1983 | 1358 | 0.020 |
Why?
|
Interferons | 1 | 2009 | 703 | 0.020 |
Why?
|
Myelodysplastic Syndromes | 2 | 2011 | 1345 | 0.020 |
Why?
|
Aging | 1 | 2004 | 8613 | 0.020 |
Why?
|
Insulin | 1 | 2020 | 6569 | 0.020 |
Why?
|
Hydroxymethylglutaryl CoA Reductases | 1 | 2005 | 59 | 0.020 |
Why?
|
Integrin beta Chains | 1 | 2005 | 121 | 0.020 |
Why?
|
Streptozocin | 1 | 2005 | 191 | 0.020 |
Why?
|
Retroviridae | 1 | 2008 | 913 | 0.020 |
Why?
|
Glucokinase | 1 | 2005 | 103 | 0.020 |
Why?
|
Drosophila | 1 | 1993 | 1478 | 0.020 |
Why?
|
Mitochondria | 1 | 2018 | 3522 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2015 | 2948 | 0.020 |
Why?
|
Phospholipids | 1 | 1989 | 783 | 0.020 |
Why?
|
Glycogen | 1 | 2005 | 263 | 0.020 |
Why?
|
Chimera | 2 | 1997 | 488 | 0.020 |
Why?
|
Mice, Inbred CBA | 1 | 2005 | 446 | 0.020 |
Why?
|
Ubiquitin | 1 | 2010 | 847 | 0.020 |
Why?
|
Models, Structural | 1 | 2005 | 361 | 0.020 |
Why?
|
Aged, 80 and over | 4 | 2013 | 57650 | 0.020 |
Why?
|
Eosinophil Peroxidase | 2 | 1994 | 20 | 0.020 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2007 | 618 | 0.020 |
Why?
|
Dystroglycans | 1 | 2004 | 60 | 0.020 |
Why?
|
Infant | 1 | 2006 | 34923 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2010 | 2092 | 0.020 |
Why?
|
R-SNARE Proteins | 1 | 2004 | 75 | 0.020 |
Why?
|
PPAR alpha | 1 | 2005 | 196 | 0.010 |
Why?
|
Ovalbumin | 1 | 2005 | 721 | 0.010 |
Why?
|
Culture Techniques | 1 | 2004 | 557 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2014 | 2910 | 0.010 |
Why?
|
Antibodies | 1 | 2012 | 2450 | 0.010 |
Why?
|
Flavonoids | 1 | 2006 | 443 | 0.010 |
Why?
|
Serine Endopeptidases | 1 | 2009 | 1070 | 0.010 |
Why?
|
Child, Preschool | 1 | 2006 | 40802 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 1992 | 4768 | 0.010 |
Why?
|
Protein Structure, Secondary | 1 | 2006 | 1245 | 0.010 |
Why?
|
Survival Rate | 2 | 2010 | 12761 | 0.010 |
Why?
|
Apolipoproteins | 1 | 2005 | 315 | 0.010 |
Why?
|
Models, Molecular | 2 | 2004 | 5460 | 0.010 |
Why?
|
Leukocytosis | 1 | 2004 | 247 | 0.010 |
Why?
|
Intracellular Space | 1 | 2004 | 211 | 0.010 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2006 | 704 | 0.010 |
Why?
|
Cyclin-Dependent Kinase 2 | 1 | 2003 | 191 | 0.010 |
Why?
|
Immunity, Innate | 1 | 2014 | 2950 | 0.010 |
Why?
|
Life Tables | 1 | 2003 | 370 | 0.010 |
Why?
|
Wound Healing | 1 | 2013 | 2768 | 0.010 |
Why?
|
Immunologic Factors | 1 | 1992 | 1571 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2011 | 9812 | 0.010 |
Why?
|
Cytosol | 1 | 2005 | 902 | 0.010 |
Why?
|
Polyethylene Glycols | 1 | 2008 | 1182 | 0.010 |
Why?
|
Receptor Cross-Talk | 1 | 2002 | 118 | 0.010 |
Why?
|
Base Composition | 1 | 1982 | 294 | 0.010 |
Why?
|
Macaca | 1 | 1983 | 443 | 0.010 |
Why?
|
Embryonic Development | 1 | 2007 | 701 | 0.010 |
Why?
|
Extracellular Space | 1 | 2004 | 594 | 0.010 |
Why?
|
Cell Adhesion Molecules | 1 | 1988 | 1599 | 0.010 |
Why?
|
Receptors, Immunologic | 1 | 1988 | 1424 | 0.010 |
Why?
|
Escherichia coli | 2 | 1993 | 4220 | 0.010 |
Why?
|
Tamoxifen | 1 | 2006 | 978 | 0.010 |
Why?
|
Cyclic AMP | 1 | 2005 | 1470 | 0.010 |
Why?
|
Eosinophil-Derived Neurotoxin | 2 | 1992 | 13 | 0.010 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 1983 | 794 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2013 | 9122 | 0.010 |
Why?
|
Quinolines | 1 | 2006 | 721 | 0.010 |
Why?
|
Protein Kinases | 1 | 2008 | 1637 | 0.010 |
Why?
|
Antigens, Polyomavirus Transforming | 1 | 1981 | 257 | 0.010 |
Why?
|
Deoxyribonucleases | 1 | 1982 | 213 | 0.010 |
Why?
|
Blood Vessels | 1 | 2007 | 1126 | 0.010 |
Why?
|
Nerve Growth Factors | 1 | 2004 | 578 | 0.010 |
Why?
|
Frameshift Mutation | 1 | 2003 | 398 | 0.010 |
Why?
|
Glucocorticoids | 1 | 2010 | 2100 | 0.010 |
Why?
|
Drug Interactions | 1 | 2005 | 1456 | 0.010 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2002 | 502 | 0.010 |
Why?
|
Glioblastoma | 1 | 2015 | 3431 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2006 | 2634 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8274 | 0.010 |
Why?
|
Temperature | 2 | 1977 | 2202 | 0.010 |
Why?
|
Fatty Liver | 1 | 2005 | 714 | 0.010 |
Why?
|
Health Status Disparities | 1 | 2011 | 1776 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2008 | 6397 | 0.010 |
Why?
|
Ion Channels | 1 | 2004 | 1056 | 0.010 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2008 | 2102 | 0.010 |
Why?
|
Cytoskeleton | 1 | 2004 | 1181 | 0.010 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2007 | 3453 | 0.010 |
Why?
|
Zinc | 1 | 2002 | 683 | 0.010 |
Why?
|
Yeasts | 1 | 1999 | 285 | 0.010 |
Why?
|
Child | 1 | 2006 | 77033 | 0.010 |
Why?
|
Cytoskeletal Proteins | 1 | 2004 | 1369 | 0.010 |
Why?
|
Diet | 1 | 2016 | 7876 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2009 | 3504 | 0.010 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2006 | 1497 | 0.010 |
Why?
|
Prostate | 1 | 2006 | 1743 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2017 | 12178 | 0.010 |
Why?
|
Triglycerides | 1 | 2005 | 2447 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2004 | 3137 | 0.010 |
Why?
|
Carcinoma | 1 | 1988 | 2361 | 0.010 |
Why?
|
Astrocytes | 1 | 2004 | 1258 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1999 | 1800 | 0.010 |
Why?
|
Receptors, Erythropoietin | 1 | 1996 | 147 | 0.010 |
Why?
|
Cholesterol | 1 | 2005 | 2900 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2004 | 3603 | 0.010 |
Why?
|
Histocompatibility Antigens | 1 | 1977 | 473 | 0.010 |
Why?
|
Stem Cell Transplantation | 1 | 2004 | 1628 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2005 | 2455 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2013 | 21694 | 0.010 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 1995 | 248 | 0.010 |
Why?
|
HIV-1 | 1 | 1993 | 6931 | 0.010 |
Why?
|
Germinal Center | 1 | 1997 | 373 | 0.010 |
Why?
|
Butyric Acid | 1 | 1994 | 55 | 0.010 |
Why?
|
Body Weight | 1 | 2005 | 4660 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 2005 | 3036 | 0.010 |
Why?
|
Brain | 1 | 2021 | 26345 | 0.010 |
Why?
|
Computational Biology | 1 | 2006 | 3506 | 0.010 |
Why?
|
3T3 Cells | 1 | 1995 | 1103 | 0.010 |
Why?
|
Enzyme Induction | 1 | 1994 | 475 | 0.010 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 1996 | 432 | 0.010 |
Why?
|
Butyrates | 1 | 1994 | 165 | 0.010 |
Why?
|
Cricetinae | 1 | 1977 | 2468 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2004 | 8299 | 0.010 |
Why?
|
Chloramphenicol O-Acetyltransferase | 1 | 1993 | 222 | 0.010 |
Why?
|
False Positive Reactions | 1 | 1995 | 982 | 0.010 |
Why?
|
Biopsy | 1 | 2005 | 6722 | 0.010 |
Why?
|
Microscopy, Immunoelectron | 1 | 1992 | 319 | 0.010 |
Why?
|
Immunoglobulin M | 1 | 1997 | 1537 | 0.010 |
Why?
|
Sialomucins | 1 | 1992 | 15 | 0.010 |
Why?
|
Dimethyl Sulfoxide | 1 | 1993 | 246 | 0.010 |
Why?
|
Subcellular Fractions | 1 | 1992 | 547 | 0.010 |
Why?
|
Hippocampus | 1 | 2004 | 3657 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2013 | 38942 | 0.010 |
Why?
|
Amino Acids | 1 | 1977 | 1727 | 0.010 |
Why?
|
Risk | 1 | 2003 | 9684 | 0.010 |
Why?
|
Gene Rearrangement | 1 | 1996 | 1178 | 0.010 |
Why?
|
Genetic Markers | 1 | 1996 | 2630 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2002 | 4454 | 0.010 |
Why?
|
Mucins | 1 | 1992 | 563 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 1992 | 2503 | 0.010 |
Why?
|
Protein Sorting Signals | 1 | 1989 | 280 | 0.000 |
Why?
|
Hemoglobinuria, Paroxysmal | 1 | 1989 | 102 | 0.000 |
Why?
|
Artifacts | 1 | 1995 | 1905 | 0.000 |
Why?
|
Lymphocyte Activation | 1 | 1997 | 5522 | 0.000 |
Why?
|
Infant, Newborn | 1 | 2003 | 25470 | 0.000 |
Why?
|
Prospective Studies | 1 | 2007 | 53037 | 0.000 |
Why?
|
Retrospective Studies | 1 | 2010 | 76631 | 0.000 |
Why?
|
DNA Restriction Enzymes | 1 | 1976 | 570 | 0.000 |
Why?
|
Nucleic Acid Denaturation | 1 | 1976 | 110 | 0.000 |
Why?
|
Complement Fixation Tests | 1 | 1975 | 78 | 0.000 |
Why?
|
Risk Factors | 1 | 2003 | 71974 | 0.000 |
Why?
|
Coliphages | 1 | 1975 | 120 | 0.000 |
Why?
|
Chromatography, Ion Exchange | 1 | 1975 | 305 | 0.000 |
Why?
|
Antigen-Antibody Reactions | 1 | 1975 | 364 | 0.000 |
Why?
|
Drug Stability | 1 | 1975 | 292 | 0.000 |
Why?
|
RNA, Viral | 1 | 1981 | 2907 | 0.000 |
Why?
|
Macromolecular Substances | 1 | 1975 | 1457 | 0.000 |
Why?
|